Beddingfield III Frederick 4
4 · Sienna Biopharmaceuticals, Inc. · Filed Jul 3, 2019
Insider Transaction Report
Form 4
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2019-07-02$0.76/sh−17,063$12,968→ 817,599 total
Holdings
- 112,614(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Represents shares otherwise issuable to the Reporting Person that were withheld to satisfy the Issuer's tax withholding obligation upon settlement of restricted stock units.
- [F2]This transaction was executed in multiple trades in prices ranging from $0.72 to $0.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes a total of 5,916 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.
- [F4]The shares are directly held by the Beddingfield Family Trust.